Cargando…

LOX-1: Implications in atherosclerosis and myocardial ischemia

Understanding the pathophysiology of atherosclerosis is fundamental to the practice of cardiovascular medicine. Atherosclerosis is a multi-step cascade of accumulation of lipids and downstream changes that lead to a fibro-fatty plaque formation in the arterial intima. Multiple biochemical stimuli, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Tanya, Romeo, Francesco, Mehta, Jawahar L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971323/ https://www.ncbi.nlm.nih.gov/pubmed/35368459 http://dx.doi.org/10.17179/excli2021-4532

Ejemplares similares

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
por: Kattoor, Ajoe John, et al.
Publicado: (2019)

LOX-1 and Angiotensin Receptors, and Their Interplay
por: Wang, Xianwei, et al.
Publicado: (2011)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence
por: Khaidakov, Magomed, et al.
Publicado: (2011)

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension
por: Li, Xiao, et al.
Publicado: (2021)

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset
por: Di Rienzo, Carmine, et al.
Publicado: (2013)

MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1
por: Dai, Yao, et al.
Publicado: (2016)

MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1
por: Dai, Yao, et al.
Publicado: (2018)

Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein
por: Thakkar, Shraddha, et al.
Publicado: (2015)

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression
por: Ding, Zufeng, et al.
Publicado: (2013)

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies
por: Rizzacasa, Barbara, et al.
Publicado: (2017)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease
por: Twigg, M. W, et al.
Publicado: (2012)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments
por: Shaw, Daniel, et al.
Publicado: (2020)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

Myocardial Ischemia in Wegener’s Granulomatosis: Coronary Atherosclerosis Versus Vasculitis
por: Cocco, Giuseppe, et al.
Publicado: (2010)

MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo
por: Liu, Mingxin, et al.
Publicado: (2017)

Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis
por: Li, Wei, et al.
Publicado: (2020)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

Atherosclerosis, Ischemia, and Anticancer Drugs
por: Singh, Shailesh, et al.
Publicado: (2021)

Implications of Myocardial Bridge on Coronary Atherosclerosis and Survival
por: Darabont, Roxana Oana, et al.
Publicado: (2022)

Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1
por: Yan, Sishan, et al.
Publicado: (2018)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

Mental Stress-Induced Myocardial Ischemia
por: Mehta, Puja K., et al.
Publicado: (2022)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)
por: He, Jianfeng, et al.
Publicado: (2022)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

Loneliness and Social Isolation: Determinants of Cardiovascular Outcomes
por: Sharma, Tanya, et al.
Publicado: (2021)

Ursolic Acid Attenuates Atherosclerosis in ApoE(−/−) Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway
por: Li, Qiu, et al.
Publicado: (2018)

Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis
por: Ding, Zufeng, et al.
Publicado: (2013)

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells
por: Gioia, Magda, et al.
Publicado: (2015)

Functional Analysis and Molecular Dynamics Simulation of LOX-1 K167N Polymorphism Reveal Alteration of Receptor Activity
por: Biocca, Silvia, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kg6ujhk3rmqp6v29aamgub988l